Navigation Links
UC San Diego engineers develop novel method for accelerated bone growth
Date:1/30/2009

ch to clinical application, said Shu Chien, a UC San Diego bioengineering professor and director of the university's new Institute of Engineering in Medicine (IEM). Chien said this effort will be fostered by the IEM, whose goal is to bring together scientists, engineers and medical experts to come up with novel approaches to medicine.

"Our research in this area has pointed to a novel way by which we can modulate the stem cell differentiation, which is very important in regenerative medicine," Chien said. "This will lead to a truly interdisciplinary approach between engineering and medicine to getting novel treatments to the clinic to benefit the patients."


'/>"/>

Contact: Andrea Siedsma
asiedsma@soe.ucsd.edu
858-822-0899
University of California - San Diego
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New Palliative Medicine Hotline to Call San Diego Home
2. San Diego Attorney Provides Emergency Medical Relief to War Torn Gaza Strip
3. UC San Diego scientists developing brain imaging methods for studying natural human behavior
4. UC San Diego announces collaboration with Johnson & Johnson Pharmaceutical Research & Development
5. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
6. Centennial Taking Control of Your Diabetes Conference Returns to San Diego to Bring Answers, Advocacy and Hope
7. Dr. Ron Greenspan has Been Selected for the 2008 Best of San Diego Award in the Orthodontists Category by the U.S. Local Business Association
8. Car Donations: "Tired Wheels" Turned Into Donation Dollars for Ronald McDonald House Charities, San Diego
9. UC San Diego to lead nationwide program in pharmacogenomics
10. Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
11. Graves & Thyroid Disease National Patient Conference Set for San Diego, CA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... ... Telehealth represents a growing trend among Blue Cross and Blue Shield plans, with ... 12 Blues plan clients. The September 2015 issue of The AIS Report ... executives at Capital Blue Cross, whose telehealth services will launch next year. Published independently ...
(Date:9/2/2015)... ... ... Date and time: Oct. 3, 2015, 9 a.m. to 4 p.m. ... Athyn, Pa 19009 , Cost: $50 per person; includes lunch , The Quakertown, Pa.-based ... Sam Keen based on his new book which he co-authored with his son, Gifford ...
(Date:9/2/2015)... ... September 02, 2015 , ... RxNT , an innovative ... its enhanced, cloud-based mobile ePrescribing application. The release of this enhanced iPhone app ... A leader in health technology, RxNT was one of the first to build ...
(Date:9/2/2015)... ... 02, 2015 , ... Care Providers and their medical billing ... include EOBs, payments, and payment related documents. AD-EOB A/R helps them sort, index ... billing, with one efficient process and interface,“ stated Rich Caproni, AliusDoc’s Director of ...
(Date:9/2/2015)... ... September 02, 2015 , ... Good health and a good ... Shield of New Jersey (Horizon BCBSNJ) donated $11,000 to the New Jersey Golf Foundation ... foundation at the start of The Barclays, Horizon BCBSNJ challenged PGA TOUR golfer and ...
Breaking Medicine News(10 mins):Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 2Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 3
... devices help babies survive, thrive into adulthood, study shows , ... that was typically fatal three decades ago is no longer ... allow babies to survive well into adulthood, researchers report. , ... New England Journal of Medicine compares the effectiveness of ...
... of the National Academies will convene a regional meeting ... Chicago to discuss the rapidly rising rates of diabetes ... Conference on Diabetes and Obesity will bring together leading ... preventive measures and policy issues will be discussed by ...
... hormone that triggers the need for a night,s rest may ... News) -- Brain injuries can disrupt the body,s production of ... study suggests. , "We,ve known that people often have problems ... much about the exact causes of these problems," study author ...
... ... Product(s) Used in a Wide Variety of Arthroscopic Tenodesis Knee Procedures Such as: ACL, ... ... today it has received FDA 510k clearance for product(s) used in a wide variety ...
... , WEDNESDAY, May 26 (HealthDay News) -- Researchers report that ... the brain in mice -- a finding that could help ... who suffer from Alzheimer,s disease and stroke. , Removing clots ... blood to flow unimpeded, since blockages can lead to a ...
... Scientists are reporting development of a fast, simple, inexpensive ... workplaces may cause skin allergies in people -- a ... study appears in ACS, Chemical Research in Toxicology ... his colleagues note the existence of public sentiment against ...
Cached Medicine News:Health News:Progress Made Against Once-Fatal Heart Defect 2Health News:Progress Made Against Once-Fatal Heart Defect 3Health News:UIC to host Institute of Medicine Meeting on diabetes and obesity 2Health News:Brain Injuries May Lead to Sleep Woes 2Health News:KFx Medical Corporation Announced Today It Has Received FDA 510k Clearance for Product(s) Used in a Wide Variety of Knee Procedures 2Health News:Brain Cells May Serve as Clot-Busters 2
(Date:9/2/2015)... 2, 2015  ArmaGen, Inc., a privately held ... treat severe neurological disorders, announced today that the ... Phase 1/2a clinical trial of AGT-181 in patients ... AGT-181 is an investigational enzyme replacement ... The most severe form of MPS I, Hurler ...
(Date:9/2/2015)... , Sept. 2, 2015  Aethlon Medical, Inc. (Nasdaq: ... and CEO, will be presenting at the Rodman & Renshaw ... NY at 9:35 a.m. ET on Thursday, September ... to the public via live audio webcast which can be ... corporate website at http://www.aethlonmedical.com . The webcast will be ...
(Date:9/2/2015)... 2, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... and Chief Executive Officer, will present a corporate ... Conference, sponsored by H.C. Wainwright & ... 2015 at the St. Regis Hotel in New ...
Breaking Medicine Technology:ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4RegeneRx to Present at Rodman & Renshaw Global Investment Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 3
... With 30 Installed Inveon Imaging Systems, Siemens ... Position in Preclinical Imaging Centers, HOFFMAN ... adage,says "a picture is worth 1,000 words," ... research where high-resolution images can validate years ...
... Results Seen Since Presentation ... to Include Alvespimycin Plus Trastuzumab Plus ... Paclitaxel Regimen, HAYWARD, ... data from a Phase 1 clinical,trial showing that alvespimycin, its second-generation Hsp90 ...
Cached Medicine Technology:Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 2Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 3Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 4Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 5Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial 2Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial 3Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial 4Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial 5
AUTION ELEVEN is the eleventh model of AUTION series which is ideal for use in small-to-medium-sized hospitals and clinics with its smart design and features....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Stat Detection of Soluble Fibrin Monomer Complexes by the Hemagglutination Technique, 32 tests....
Medicine Products: